Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 1965, 30, 3001-3006
https://doi.org/10.1135/cccc19653001

On the metabolism of 5-azacytidine and 5-aza-2'-deoxycytidine in mice

K. Raška, Jr., M. Jurovčík, Z. Šormová and F. Šorm

Crossref Cited-by Linking

  • Delchev V. B., Shterev I. G.: CRYSTAL STRUCTURE AND PHOTOCHEMISTRY OF 5-AZACYTOSINE: EXPERIMENTAL AND THEORETICAL STUDY. J Struct Chem 2022, 63, 319. <https://doi.org/10.1134/S0022476622030015>
  • Zhou Zhongneng, Hu Zhubin, Zhang Xianwang, Jia Menghui, Wang Xueli, Su Hongmei, Sun Haitao, Chen Jinquan, Xu Jianhua: pH Controlled Intersystem Crossing and Singlet Oxygen Generation of 8‐Azaadenine in Aqueous Solution. ChemPhysChem 2019, 20, 757. <https://doi.org/10.1002/cphc.201800969>
  • Ziemba Amy, Hayes Eugene, Freeman Burgess B., Ye Tao, Pizzorno Giuseppe: Development of an Oral Form of Azacytidine: Triacetyl-5-Azacytidine. Chemotherapy Research and Practice 2011, 2011, 1. <https://doi.org/10.1155/2011/965826>
  • Ueno Masaki, Katayama Kei-ichi, Yasoshima Akira, Nakayama Hiroyuki, Doi Kunio: 5-Azacytidine (5AzC)-induced histopathological changes in the central nervous system of rat fetuses. Experimental and Toxicologic Pathology 2002, 54, 91. <https://doi.org/10.1078/0940-2993-00239>
  • Hossain Mokbul Md., Nakayama Hiroyuki, Goto Naoaki: Apoptosis in the Central Nervous System of Developing Mouse Fetuses from 5-Azacytidine-Administered Dams. Toxicol Pathol 1995, 23, 367. <https://doi.org/10.1177/019262339502300313>
  • Kurishita Akihiro, Ihara Toshio: Inhibitory effects of cobalt chloride and cinnamaldehyde on 5‐azacytidine‐induced digital malformations in rats. Teratology 1990, 41, 161. <https://doi.org/10.1002/tera.1420410206>
  • Kurishita Akihiro, Ihara Toshio: Inhibitory effect of caffeine on 5‐azacytidine‐induced digital malformations in the rat. Teratology 1987, 35, 247. <https://doi.org/10.1002/tera.1420350211>
  • Waalkes Michael P., Poirier Lionel A.: Induction of hepatic metallothionein following 5-azacytidine administration. Toxicology and Applied Pharmacology 1985, 79, 47. <https://doi.org/10.1016/0041-008X(85)90367-9>
  • Momparler Richard L.: Molecular, cellular and animal pharmacology of 5-AZA-2′-deoxycytidine. Pharmacology & Therapeutics 1985, 30, 287. <https://doi.org/10.1016/0163-7258(85)90053-1>
  • Schmahl W., Török† P., Kriegel H.: Embryotoxicity of 5-azacytidine in mice phase- and dose-specificity studies. Arch Toxicol 1984, 55, 143. <https://doi.org/10.1007/BF00346054>
  • Kelly Cecil J., Coles Eric, Gaudio Linda, Yesair David W.: Characterization of the urinary metabolites of 5-azacytidine in mice. Biochemical Pharmacology 1980, 29, 609. <https://doi.org/10.1016/0006-2952(80)90384-6>
  • Veselý Jiří, Čihák Alois: 5-Azacytidine: Mechanism of action and biological effects in mammalian cells. Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors 1978, 2, 813. <https://doi.org/10.1016/0362-5478(78)90016-5>
  • Weiss John W., Pitot Henry C.: Inhibition of ribosomal ribonucleic acid maturation by 5-azacytidine and 8-azaguanine in Novikoff hepatoma cells. Archives of Biochemistry and Biophysics 1974, 160, 119. <https://doi.org/10.1016/S0003-9861(74)80016-0>
  • Chabner Bruce A., Drake James C., Johns David G.: Deamination of 5-azacytidine by a human leukemia cell cytidine deaminase. Biochemical Pharmacology 1973, 22, 2763. <https://doi.org/10.1016/0006-2952(73)90137-8>
  • Evans J. S., Haňka L. J.: The in vivo activity of combinations of 5-azacytidine and cytidine on leukemia L-1210. Experientia 1968, 24, 922. <https://doi.org/10.1007/BF02138656>
  • Veselý J., Čihák A., Šorm F.: Biochemical mechanism of drug resistance—VII. Biochemical Pharmacology 1968, 17, 519. <https://doi.org/10.1016/0006-2952(68)90267-0>